New Indirect Calorimetry Device for Energy Expenditure Measurement
NCT ID: NCT02024958
Last Updated: 2017-10-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
182 participants
OBSERVATIONAL
2017-05-01
2018-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objectives: Validation of a reliable and easy-to-use IC device.
Primary objective:
• Accuracy of EE measurements (kcal/d measured over 30 min) of the new and the reference IC devices in intubated ICU patients on mechanical ventilation
Secondary objectives:
* Accuracy of EE measurements in ICU patients of spontaneous breathing
* Accuracy of EE measurement during \~30 min. vs. the sum of 6 periods of 60 min/12 hrs
* Accuracy of EE measurements in ICU patients on non-invasive mechanical ventilation
Design: Prospective, controlled, observational multicenter study.
Subjects: 182 ICU patients.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objectives: Validation of a reliable and easy-to-use IC device.
Primary objective:
• Accuracy of EE measurements (kcal/d measured over 30 min) of the new and the reference IC devices in intubated ICU patients on mechanical ventilation
Secondary objectives:
* Accuracy of EE measurements in ICU patients of spontaneous breathing
* Accuracy of EE measurement during \~30 min. vs. the sum of 6 periods of 60 min/12 hrs
* Accuracy of EE measurements in ICU patients on non-invasive mechanical ventilation Design: Prospective, controlled, observational multicenter study. Subjects: 182 ICU patients. Sample size calculation is based on the estimated accuracy of the new IC device compared to the Deltatrac, when performed simultaneously on one subject. In a previous study, we found a difference of EE between the Deltatrac and the Quark RMR of 24±220 kcal, thus a coefficient of variation (SD/mean) of 8.8 %. We hypothesized a difference of 25±50 kcal when comparing the Deltatrac with the new IC device, thus a coefficient of variation of 2%. This reduction of 6.5% of the coefficient variation, with a power of 90% and a significance level of 0.05 was used to calculate a required sample size of 91 subjects. A drop out rate of 50% is anticipated, leading to 182 patients to be recruited to allow an analysis based on 91 patients with optimal measurements.
Inclusion criteria:
• Adult ICU patients with spontaneous breathing, or on invasive or non-invasive mechanical ventilation.
Exclusion criteria:
* FiO2 \> 60%
* Kidney failure requiring Continous veno-venous hemofiltration (CVVH)
* Conditions promoting air leaks: Positive end-expiratory pressure (PEEP) \>10, Peak ventilatory pressure \> 30
* Chest tube (except if only for liquid drainage = no bubbling)
* Unstable hemodynamic conditions requiring changes in vasoactive drugs either 1 hour before and/or during the IC measurement (i.e. all conditions resulting in unstable pH during IC measurements).
* Change in body temperature \>0.5°C either 1 hr before and/or during the IC measurement
* Physical agitation or curarization either 1 hour before and/or during the IC measurement
Outcomes:
Primary outcome:
• EE in intubated ICU patients on mechanical ventilation
Secondary outcomes:
* EE in ICU patients of spontaneous breathing
* EE during \~30 minutes vs. the sum of 6 periods of 60 minutes/12 hours
* EE measurements when using different types of ventilators
* Time to start EE measurement (calibration, warming up)
* Duration for IC disinfection New Calorimeter - Protocol - November 11. 2013 Page 3 sur 5
* Limitations of EE measurements in patients on non-invasive mechanical ventilation
Indirect calorimetry devices and methodology:
* New IC device (Cosmed, Italy) and Deltatrac II (Datex, Finland).
* Briefly, patients are laying down in a supine position on a bed during ongoing measure of \~30 min (see Figure 1) by connecting the calorimeter to the endotracheal tube (invasive mechanical ventilation) or to the facemask (non-invasive mechanical ventilation), or by using a transparent canopy in plexiglas to cover the head while room-air flows through and is mixed with the expirate (spontaneous breathing). This mixture of patient breath and room air is finally collected and analyzed by the IC device for O2 and CO2 concentrations, and used to calculate EE. The first 2 min of data is eliminated as acclimatization artefact. From the remaining \~28 min, a segment of 5 consecutive 1-min measures with 5% coefficient of variation in VO2 and VCO2 is considered as steady state.
Barometric pressure is recorded. EE is calculated using the modified Weir equation.
* Calibration of the gas analyzers is carried out before /after each measurement according to the manufacture instructions, including ethanol burning for the Deltatrac II.
* EE measurements is performed simultaneously by the 2 IC devices.
Data collected:
* Sex, Age (yr), height (±2 cm), dry weight (±1kg)
* Heart rate, Body temperature
* Admission diagnosis, Major treatments
* SAPS II and SOFA on ICU admission day; SOFA on the study day
* Ventilator type (name) and ventilation mode (Minute ventilation, FiO2)
* Inspiratory and expiratory O2, CO2, air flow (ml/min) measured by the IC
Statistics and data analysis:
The Coordinating center analyses the data transferred by the Investigation centers
* All data are reported as means±SD. The parameters (see above) of the two IC devices is compared by Bland and Altman plots
* Reliability and adequacy (sensitivity, specificity, positive and negative predictive values) between the IC devices, is tested using ROC curves with kappa coefficient (reliability coefficient). For coefficient of variation, ANOVA is used when applicable. Results are adjusted using Greenhouse-Geisser correction in case of non-sphericity. Post-hoc tests using Bonferroni correction compared the results between two IC devices. The prediction of EE differences between devices are analyzed by multivariate regression. As 91 are expected to complete the entire protocol, 9 factors are introduced in the model (Peduzzi P, J Clin Epidemiol 1996, 49, 1373-9), i.e. ventilator type, ventilator mode, minute ventilation, FiO2, BMI, SOFA, heart rate, body temperature, medical/surgical category.
Statistical analysis significance is set at p\<0.05.
For the subgroup of patients with prolonged EE measurements or on non-invasive ventilation:
Univariate and multivariate analysis are used to analyze the factors associated with observed variations.
Value of the study for clinical practice practice and research:
An accurate and reliable IC for nutrition specialists will allow to optimize energy prescription, a factor shown to improve the clinical outcome. An easy-to-use and affordable (10'000 $) IC will reduce both the burden on human resources and costs.
Study originality:
* Development of an IC device meeting technical characteristics defined by physicians (bottom-up strategy)
* Demonstration of the clinical relevance of short EE measurements, practically convenient and less human-resources consuming, versus longer EE measurements New Calorimeter - Protocol - November 11. 2013 Page 4 sur 5
* Exploratory comparative tests, whenever possible, to evaluate IC in a subgroup of patients with non-invasive ventilation New Calorimeter - Protocol - November 11. 2013 Page 5 sur 5
Agenda of actions:
* The IC prototype will be made available the 18th of May 2014.
* Recruitment of subjects will begin in May-June 2014 and will continue for 1 year, or until sufficient subjects are included in the study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
indirect calorimetry measurement
Measurement of energy expenditure in made by indirect calorimetry in patients laying down in a supine position on a bed during ongoing measure by connecting the calorimeter to the endotracheal tube (invasive mechanical ventilation) or to the facemask (non-invasive mechanical ventilation), or by using a transparent canopy in plexiglas to cover the head while room-air flows through and is mixed with the expirate (spontaneous breathing). This mixture of patient breath and room air is finally collected and analyzed by the IC device for O2 and CO2 concentrations, and used to calculate EE. EE is calculated using the modified Weir equation.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Kidney failure requiring Continous veno-venous hemofiltration (CVVH)
* Conditions promoting air leaks: Positive end-expiratory pressure (PEEP) \>10, Peak ventilatory pressure \> 30
* Chest tube (except if only for liquid drainage = no bubbling)
* Unstable hemodynamic conditions requiring changes in vasoactive drugs either 1 hour before and/or during the IC measurement (i.e. all conditions resulting in unstable pH during IC measurements).
* Change in body temperature \>0.5°C either 1 hr before and/or during the IC measurement
* Physical agitation or curarization either 1 hour before and/or during the IC measurement
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Helse-Bergen HF
OTHER
University of Lausanne Hospitals
OTHER
Medical University of Vienna
OTHER
Rabin Medical Center
OTHER
Karolinska University Hospital
OTHER
University Hospital, Geneva
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Claude Pichard
Professor of nutrition
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Claude Pichard, Prof
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Geneva
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Geneva University Hospital- Nutrition Unit
Geneva, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
claude Pichard, Prof
Role: primary
Claudia P Heudegger, MD
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ICALIC
Identifier Type: -
Identifier Source: org_study_id